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A B S T R A C T
Objective: To compare the frequency of cardiovascular risk factors (CVRFs) in obese patients 
of the Brazilian Unified Health System (Sistema Único de Saúde – SUS) with indication of 
bariatric surgery during the preoperative period and after the sixth month and the first year 
of the procedure. 
Methods: An observational, longitudinal, prospective, and analytical study was performed, 
with consecutive selection of obese patients with indication for surgery referred to 
preoperative cardiac evaluation. The protocol consisted of: medical history, physical 
examination, electrocardiogram, echocardiogram, and biochemical analysis. This study 
analyzed the following variables: weight, body mass index (BMI), waist circumference (WC), 
systemic arterial hypertension (SAH), diabetes mellitus type 2(DM), dyslipidemia (high LDL 
cholesterol; low HDL cholesterol; hypertriglyceridemia), and metabolic syndrome (MS). The 
chi-squared test and the Tukey-Kramer method were used for statistical analysis. 
Results: The sample was composed of 96 obese people, among which 86 were women, aged 
between 18 and 58 years old (median 35 years old). At the end of six months, significant 
reductions of 88%, 95%, 71%, 89%, and 80% in the frequency of SAH, high LDL cholesterol, 
hypertriglyceridemia, DM, and MS could already be observed. A significant and small 
reduction in the frequency of low HDL cholesterol (24%) and abnormal WC (31%) was observed 
only at the end of 12 months. After six months and one year, weight and BMI experienced 
reductions of 33.4 kg and 44.3 kg, and 13.1 kg/m2 and 17.2 kg/m2, respectively. 
Conclusion: The positive impact on weight loss and the reduction in BMI, WC, and in the 
frequency of CVRFs are already extremely significant after six months and remain so one 
year after bariatric surgery. 
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Frequência de fatores de risco cardiovascular antes e 6 e 12 meses 
após gastroplastia
R E S U M O
Objetivo: Comparar a frequência dos fatores de risco cardiovascular (FRCV) em obesos 
com indicação de gastroplastia no pré-operatório e após o sexto mês e o primeiro ano do 
procedimento, em usuários do Sistema Único de Saúde.
Métodos: Foi realizado estudo observacional, longitudinal, prospectivo e analítico, com seleção 
consecutiva de obesos com indicação cirúrgica, encaminhados para avaliação cardiológica 
pré-operatória. O protocolo foi constituído de: história clínica, exame físico,eletrocardiograma, 
ecocardiograma e dosagens bioquímicas. No presente estudo, foram analisadas as seguintes 
variáveis: peso, índice de massa corporal (IMC), circunferência abdominal (CA), hipertensão 
arterial Sistêmica (HAS), diabetes mellitus-tipo 2 (DM), dislipidemia (colesterol LDL elevado; 
colesterol HDL baixo; hipertrigliceridemia) e síndrome metabólica(SM). Para análise 
estatística foram utilizados os métodos do Qui-quadrado e Tukey-Kramer.
Resultados: A amostra foi constituída de 96 obesos. Desses, 86 eram mulheres com idades entre 
18 e 58 anos (mediana de 35 anos). Ao final de seis meses, foi observada redução significante de 
88%, 95%, 71%, 89% e 80% na frequência de HAS, colesterol LDL elevado,hipertrigliceridemia, 
DM e SM. Apenas ao final de 12 meses houve significante e modesta redução na frequência 
de colesterol HDL baixo (24%) e CA anormal (31%). Em seis meses e um ano, o peso e o IMC 
sofreram reduções respectivas de 33,4 e 44,3 kg e de 13,1 e 17,2 kg/m2.
Conclusão: O impacto positivo na perda de peso, na redução do IMC, da CA e da frequência 
dos FRCM mostrou-se extremamente significante após seis meses, e se manteve após um 
ano da gastroplastia.
Palavras-chave:
Obesidade
Hipertensão
Dislipidemia
Diabetes mellitus tipo 2
Fatores de risco
Gastroplastia
Introduction
Obesity is currently a public health problem due to its increasing 
prevalence, the high mortality rate determined by it, and 
because it increases the frequency of other diseases,1 which 
contributes to further increase the morbimortality in this group 
of individuals.2 These diseases include the cardiovascular risk 
factors (CVRFs) represented by systemic arterial hypertension 
(SAH), diabetes mellitus type 2 (DM), and dyslipidemia.3-5 
Among the anthropometric methods used to assess 
excessive body fat, the body mass index (BMI), which divides 
weight by height squared, has been the most frequently used 
in adults.2,3,6 Obesity is defined as BMI equal or higher than 
30 kg/m2.2,3,6
In a complementary manner, waist circumference (WC) 
serves as an anthropometric measurement to indicate 
intra-abdominal fat, and was incorporated as one of the 
criteria used in the diagnosis of metabolic syndrome (MS), 
characterized by a group of CVRFs and insulin resistance, 
which increases cardiovascular mortality in patients with this 
desease.3 MS is observed in over 70% of obese patients seeking 
bariatric surgery.7,8
In Brazil, 13.9% of the population is obese, while46.6% 
is  overweight (defined as BMI between 25  kg/m2  and 
29.9 kg/m2). In 2006, these prevalences were 11.4% and 42.7%, 
respectively.9 
Despite the positive impact of clinical treatment on 
obesity,1 there is an indication for bariatric surgery when the 
BMI is higher than 40 kg/m² or higher than 35 kg/m² if associated 
with chronic diseases aggravated by obesity.1,3,10 Bariatric 
surgery thus became an important therapeutic strategy for 
obesity; nowadays, gastric bypass and adjustable gastric band 
are the most widely used methods.10,11 
The Brazilian Ministry of Health approved in 2000 the 
indications for bariatric surgery in the Brazilian Unified Health 
System (Sistema Único de Saúde – SUS).12 It is estimated 
that 344,221 bariatric surgeries were performed in 2008, 
25,000 of which in Brazil.11 Currently, in Brazil, approximately 
65,000 bariatric surgeries are performed on an annual basis.
A meta-analysis of 134 studies involving approximately 
22,000 obese patients demonstrated that bariatric surgery 
determines an average reduction of 61% of the excess body 
weight, 39.7 kg of body weight, 13.2 kg/m2 in the BMI, and an 
important improvement or resolution of comorbidities.13 The 
greatest loss of excess weight and beneficial effect on 
comorbidities occur approximately one year after the surgery, 
remaining stable in most patients;14,15 much of this effect, 
however, can already be observed in the first six months.14
The objective of this study was to compare the frequency 
of CVRFs in obese patients with indication of bariatric surgery 
(gastric bypass, Fobi- Capella)16,17 during the preoperative 
period and after the sixth month and the first year of the 
procedure, in patients of the SUS.
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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Methods
An observational, longitudinal, prospective, and analytical 
study was performed with a sample of patients with 
diagnosis of obesity and indication of bariatric surgery 
(gastroplasty)10 included in the Bariatric Surgery Program of 
the Hospital Universitário Professor Alberto Antunes (HUPAA) 
of the Universidade Federal de Alagoas (UFAL). 
Patients were consecutively referred for preoperative 
cardiac evaluation and submitted to the same protocol for 
evaluation, which included: medical history (including the 
use of medicines on a regular basis), physical examination 
(including measurement of blood pressure, weight, height, 
WC), 12-lead electrocardiogram, echocardiogram, and 
biochemical analyses (fasting glucose, total cholesterol, LDL 
cholesterol, HDL cholesterol, triglyceride levels). Other heart 
tests were requested pursuant to the individual clinical 
indication (24-hourHolter monitoring, myocardial scintigraphy, 
coronary angiography, among others). 
For the diagnosis of SAH, dyslipidemias, DM, and MS, the 
parameters included in the respective guidelines from the 
Brazilian Society of Cardiology, currently described in the I 
Brazilian guideline for diagnosis and treatment of metabolic 
syndrome, were used.2
For the diagnosis of obesity based on the BMI, the criteria 
of the World Health Organization,6 also adopted in Brazil, 
were used: low weight (BMI < 18.5 kg/m2), normal weight (BMI 
between 18.5 and 24.9 kg/m2), overweight (BMI between 25 and 
29.9 kg/m2), obesity grade I (BMI between 30.0 and 34.9 kg/m2), 
obesity grade II (BMI between 35.0 and 39.9 kg/m2), and obesity 
grade III (BMI > 40 kg/m2).2,3 Severely obese patients were also 
classified as super obesity (BMI between 50 and 59.9 kg/m2) 
and super-super obesity (BMI > 60 kg/m2).2,3,5,6 WC, measured 
at halfway between the costal margin and the iliac crest, was 
considered normal when below 88 cm in women and below 
102 cm in men.2
The following variables were analyzed for this study: 
levels of obesity based on the BMI, abdominal obesity based 
on the WC, SAH, high LDL cholesterol, low HLD cholesterol, 
hypertriglyceridemia, DM, and MS.2
The Chi-squared test was used to compare proportions 
of the categorical variables, and the Tukey-Kramer method 
was used for multiple comparisons of the average continuous 
variables, before and after the bariatric surgery (after six 
months and after one year). The significance level was set at 
5% (p < 0.05).
The research project was approved by the Research Ethics 
Committee of the UFAL (process No. 011407/2010-93 of August 
30, 2010).
Results
During the period from January 2005 to June 2010, 155 obese 
patients with indication of bariatric surgery pursuant to the 
criteria established by the Brazilian Health Ministry were 
evaluated from the cardiovascular standpoint.10 Of these 
patients, 101 were submitted to bariatric surgery pursuant to 
the Fobi-Capella technique (one death occurred in the first days 
of the postoperative period; no complications were observed 
in the other patients), and 96 concluded at least one year of 
postoperative clinical follow-up, constituting the sample of this 
study. From the 54 other patients, 32 abandoned the program 
and 22 were waiting for surgery.
In this study, the sample was constituted of 10 men (10%) 
and 86 women (90%) aged between 18 and 58 years old, median 
of 35 years, and average of 37.2 ± 8.4 years.
The average and standard deviation values of the 
continuous variables in the preoperative evaluation were as 
follows: a) weight: 124.1 ± 23.3 kg; b) BMI (kg/m2): 48.1 ± 7.0; 
c) WC: 129.7 ± 14.0 cm; d) fasting glucose: 96.5 ± 26.6 mg/dL; 
e) total cholesterol: 200.0 ± 32.7 mg/dL; f) LDL cholesterol: 
125.4 ± 29.0 mg/dL; g) HDL cholesterol: 41.5 ± 8.6 mg/dL; and h) 
triglycerides: 159.2 ± 80.0 mg/dL.
Table 1 shows the distribution of the sample based on the 
BMI values before the bariatric surgery and 6 and 12 months 
after the intervention. In the table, it is notable that, one 
year after the bariatric surgery, there was a reduction of 
99% in the frequency of grade III obese patients (only one 
individual remained super obese), emergence of overweight 
patients (which became 38.5% of the sample), and only four 
individuals (4.2%) with normal BMI. It is also noted that, at 
the end of one year, 56.3% of the sample showed grade I or 
II obesity.
Table 2 shows that the impact of the bariatric surgery 
on the control of blood pressure, LDL cholesterol, DM, and 
hypertriglyceridemia, and, consequently, MS affected a lower 
number of patients after six months of surgery, without a 
significant decrease in this proportion of individuals in the 
following six months. Reduction in WC and increase in HDL 
cholesterol significantly encompassed more patients at a later 
stage, after only one year from the procedure. The metabolic 
results observed above were obtained even with only a small 
number of patients presenting normal HDL cholesterol 
concentration (24%), WC (31%), and BMI (4%) within six 
months or one year after the bariatric surgery. 
Table 3 shows the average of the different values of the 
abovementioned continuous variables, from the numerical 
standpoint, between (a) the preoperative period and the 
6th postoperative month, (b) the preoperative period and 
BMI 
(kg/m2)
Before 
(%)
After 
six months 
(%)
After 
12 months 
(%)
> 25 (Regular) 0 0 4 (4.2)
25.0-29.9 (Overweight) 0 16 (16.7) 37 (38.5)
30.0-34.9 (Grade I) 0 36 (37.5) 41 (42.7)
35.0-39.9 (Grade II) 4 (4.2) 33 (34.4) 13 (13.6)
40.0-49.9 (Grade III) 67 (69.8) 8 (8.3) 0
50.0-59.9 (Grade III) 19 (19.8) 2 (2.1%) 1 (1.0)
≥ 60 (Grade III) 6 (6.2) 1 (1.0) 0
TOTAL 96 (100) 96 (100) 96 (100)
Table 1 – Distribution of patients as to the degree of 
obesity determined by the body mass index (BMI) before 
bariatric surgery, six and twelve months later. 
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the 12th postoperative month, and (c) the sixth and the 12th 
postoperative month, as well as the significance level of these 
differences. 
In the same table, it is possible to note that there was a 
significant reduction in body weight, WC, and BMI in the first 
phase, between the preoperative period and the sixth month 
(p < 0.001), which also significantly persisted between the sixth 
and 12th month (p < 0.001). 
Regarding fasting glucose, total cholesterol, LDL cholesterol, 
and triglyceride levels, there was already a significant reduction 
in their concentrations at the end of the sixth postoperative 
month (p < 0.001), with no statistically significant reduction 
from that moment until the end of the first year after surgery 
(p > 0.05).
In particular, the effect of the bariatric surgery on the 
increase of HDL cholesterol concentration was significant only 
after the sixth month (p < 0.001).
The average and median values of the continuous variables 
six months after bariatric surgery were, respectively: a) weight: 
90.7 kg and 89.0 kg; b) BMI: 35.0 kg/m2 and 34.4 kg/m2; c) WC: 
106.4 cm and 107.0 cm; d) fasting glucose: 81.6 mg/dL and 
80.0 mg/dL; e) total cholesterol: 169.0 mg/dL and 170 mg/dL; f) LDL 
cholesterol: 106.0 mg/dL and 107.5mg/dL; g) HDL cholesterol: 
43.0 mg/dL and 43.0 mg/dL; h) triglycerides: 96.8 mg/dL and 
87.5 mg/dL. After one year of the procedure, these values were, 
respectively: a) weight: 80.2 kg and 78.0 kg; b) BMI: 31.0 kg/m2 
and 31.0 kg/m2; c) WC: 95.9 cm and 95.0 cm; d) fasting glucose: 
79.0 mg/dL and 79.0 mg/dL; e) total cholesterol: 163.0 mg/dL 
and 162.0 mg/dL; f) LDL cholesterol: 99.5 mg/dL and 97.6 mg/dL; 
g) HDL cholesterol: 46.8 mg/dL and 46.0 mg/dL; h) triglycerides: 
81.7 mg/dL and 77.5 mg/dL.
Discussion
It is estimated that there are currently one billion overweight 
adults and 500 million obese people in the world.18 In obese 
patients, the clinical treatment (behavioral changes and 
pharmacological treatment) results in reduction of only 5% to 
10% in body weight (rarely maintained), while the bariatric 
surgery (usually indicated for obese patients with BMI > 40 kg/
m2) determines a reduction of approximately 30% in body 
weight, with such results maintained in the long term.19
Due to this important reduction in body weight and in 
visceral fat, bariatric surgery determines, starting in the 
short term, a positive impact on the control/resolution of 
the comorbidities associated with obesity, including DM, 
dyslipidemia, SAH, liver disease, apnea/hypopnea sleep 
syndrome, and cardiovascular disorder.20 This beneficial 
effect is maintained in the long term, as observed in patients 
 Preoperative period (a) Sixth postoperative month (b) 12th postoperative month (c) Significance level
SAH 51 (53%) 6 (6%) 8 (8%) *axb and *axc < 0.0001
bxc = 0.78
High LDL 20 (21%) 1 (1%) 3 (3%) *axb and *axc < 0.0001
bxc = 0.62
Low HDL 78 (81%) 73 (76%) 59 (61%) axb = 0.48
*axc = 0.004; *bxc = 0.04
Hypertriglyceridemia 42 (44%)  12 (12.5%) 1 (1%) *axb and *axc < 0.0001
*bxc = 0.0025
Diabetes 27 (28%) 3 (3%) 2 (2%) *axb and *axc < 0.0001
bxc = 1.0
Metabolic syndrome 66 (69%) 13 (14%) 5 (5%) *axb and *axc < 0.0001
bxc = 0.807
Waist circumference: 
> 102 cm in men; 
> 88 cm in women.
 96 (100%) 89 (93%) 66 (69%) *axb = 0.014
*axc and *bxc < 0.0001
BMI > 25 kg/m2  96 (100%)  96 (100%) 92 (96%) axc and bxc=0.12
BMI, body mass index; HDL, HDL cholesterol; LDL, LDL cholesterol; SAH, systemic arterial hypertension.
Chi-squared test.
*p < 0.05. 
Table 2 – Distribution of the frequency of cardiovascular risk factors before and after bariatric surgery (n = 96 patients).
Variable A B C
Weight (kg) 33.4* 44.3* 10.9*
BMI (kg/m2) 13.1* 17.2* 4.1*
Waist (cm) 23.3* 33.9* 10.6*
Blood glucose (mg/dL) 14.9* 17.8* 2.9
Cholesterol (mg/dL) 31.1* 37.1* 6.0
LDL (mg/dL) 18.9* 25.9* 7.0
HDL (mg/dL) −1.6 −5.4* −3.8*
Triglycerides (mg/dL) 62.3* 77.5* 15.1
BMI, body mass index; HDL, HDL cholesterol; LDL, LDL cholesterol. 
*p < 0.001. 
Table 3 – Distribution of the average difference between 
the variables compared at two different moments. 
(A) between the preoperative period and the sixth 
postoperative month; (B) between the preoperative 
period and the first postoperative year and (C) 
between the sixth postoperative month and the first 
postoperative year.
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monitored for ten years after the procedure,10,13,15,20,21 and 
results in the reduction of cases and in cardiovascular 
mortality,22 thus making bariatric surgery the treatment of 
choice for severely obese patients in which the drug-behavioral 
therapy has failed to control weight and comorbidities.2,10,20
A meta-analysis of 89 studies performed in other countries 
regarding the impact of the bariatric surgery on the treatment 
of obesity21 showed that the average age of patients is 38 years, 
and that more than one third of these patients are women. 
Another meta-analysis involving 134 studies and an aggregate 
of 22,094 patients13 showed that 73% are women, with an 
average age of 39 years. In a sample of 35 obese patients 
submitted to bariatric surgery in a Brazilian university hospital, 
Monteiro Junior et al.7 identified 88.5% as women, with an 
average age of 38 years. As in this study, the abovementioned 
data show that the population undergoing surgical treatment 
for obesity is predominantly female and in the fourth decade 
of life, probably when the complications resulting from 
excess body weight appear from the clinical point of view. 
Additionally, obese women appear to be more motivated than 
obese men to lose weight, as a result of social pressures with 
respect to aesthetics.23
Most authors7,13,20,21 report the impact of bariatric surgery 
on the reduction of body weight and control of cardiovascular 
risk factors one and three years after surgery, because of its 
greater clinical relevance. Within this period, a reduction of 
20 kg to 30 kg in the body weight is expected, approximately 
35% of the BMI, and resolution of SAH, DM, and dyslipidemia 
in 62%, 76%, and 70% of the individuals,7,13,20,21 respectively, 
with a lower impact on the increase in HDL cholesterol and 
reduction in WC.7,13,20,21 In the present study, it was observed 
that, at the end of the sixth month after bariatric surgery, these 
expected results were already observed, and were maintained 
until the end of the first year.
Regarding the anthropometric data, the results presented 
here showed an average reduction of 33.4 kg in body weight, 
of 13.1 kg/m2 in the BMI (a reduction of 27%), and of 23.3 cm 
in the WC six months after bariatric surgery. Santos,24 when 
evaluating 15 obese patients six months after bariatric surgery, 
observed an average reduction of 41 kg in the body weight 
and 15.4 kg/m2 in the BMI (a reduction of 28%). Both works 
identified an acceleration of the positive results of bariatric 
surgery regarding body weight and BMI, referred to in other 
groups as relevant only at the end of the first year.7,13,20,21
When analyzing the frequency of several cardiovascular risk 
factors, in the present a drastic reduction in the prevalence of 
SAH (53% X *6% X 8%), high LDL cholesterol (21% X *1% X 3%), 
DM (28% X *3% X 2%), and MS (69% X *14% X 5%) was already 
observed in the sixth month, with no significant difference in 
these frequencies between the sixth month and the first year 
after the procedure. This reduction, ranging from 71% to 95%, 
exceeds that of meta-analyses involving over 30,000 patients 
undergoing bariatric surgery (between 60% and 70%),13,21 which 
evidences the importance of the earlier assessment of these 
patients for nutritional adjustments necessary due to a 
rapid weight loss and, consequently, a rapid loss of essential 
nutrients.25
HDL cholesterol concentrations showed a late increase, so 
that a significant reduction in the frequency of individuals 
with improvement in this variable (81% X 76% X *61%) was 
observed only at the end of one year; a similar trend to that 
observed with the reduction in the WC, which showed a 
significant normalization in 31% of the sample only at the 
end of one year (100% X 93% X *69%). Monteiro et al. observed 
a reduction of 45.8% in the WC of obese patients three years 
after the bariatric surgery,7 so the observed reduction of 31% 
in the present study appears to follow the expected natural 
course after surgical intervention.20 A slow increase in HDL 
cholesterol concentrations has been observed after reduction 
in body weight in all individuals submitted to bariatric surgery, 
with higher impact on those who had bypass surgery.20
There was a significant reduction in the triglyceride 
concentrations during the first year after surgery, with a 
significant reduction in the prevalence of hypertriglyceridemia 
both at the end of the sixth month and at the end of the 
first year of follow-up (44% X *12,5% X *1%). It is known that 
the triglyceride concentrations are consistently reduced 
immediately after surgery and maintained in the long term, 
even if the patient regains weight.20 More significant reductions 
are observed after gastric bypass surgery, when compared to 
the restrictive surgery.13,15
The improvement of the lipid profile in obese patients 
determined by the bariatric surgery, as observed in this 
investigation, appears to be related to weight loss and the 
consequent improvement of the hepatic insulin sensitivity; 
however, the exact mechanism of these benefits is not fully 
clear.20 
The findings above unquestionably show the efficacy of 
the bariatric surgery in the treatment of obesity in selected 
patients,2,10,20 and it is worth mentioning that the beneficial 
effect observed in the metabolic and cardiovascular profile of 
the study population occurred after six months or one year 
of follow-up, even with only 4% of the sample reaching the 
normalization of BMI at that moment. Together, the results 
showed the importance of maintaining the nutritional and 
behavioral actions that will contribute to obtain an ideal 
weight2 and to prevent any weight gain that could lead these 
patients back to the risk situations they faced before the 
bariatric surgery.20 
Additionally, given that patients undergoing bariatric 
surgery evolve with higher risk of developing nutritional 
deficiencies caused by their consequent limitation in the 
intake and absorption of different nutrients,26 this study also 
evidenced the need for a nutritional assessment immediately 
after the bariatric surgery, in order to continuously guide this 
supplementation. Thus, the essential measures for ensuring 
the replacement of the necessary nutrients can be quickly 
identified.26
In 1998, 40,000 bariatric surgeries were performed across 
the world, 146,301 in 2003, and 344,221 in 2008.Thus, between 
1998  and 2003  there was an increment of 266% in the 
number of surgeries performed; between 2003 and 2008, the 
increment was of 125%; and considering the interval between 
1998 and 2008, the increment was of 761%.11 The safety of 
this procedure, evidenced by the low rates (4.3%) of early 
and late complications (venous thromboembolism, surgical 
reinterventions, and long hospital stays) and a mortality 
rate of 0.3% in the first month of the postoperative period in 
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samples with thousands of patients,27 together with the good 
results, support its insertion as an important strategy in the 
treatment of severe obesity.2,10,12,20 In the present study, a 
mortality rate of 0.9% (1/101 patients) was observed in the first 
month of the postoperative period, caused by fatal pulmonary 
thromboembolism; no other complications were identified.
Based on the results presented here, it can be concluded 
that the positive impact of the bariatric surgery on weight loss, 
reduction in BMI, WC, and in the frequency of cardiovascular 
risk factors is already extremely significant after six months 
and is maintained one year after the procedure.
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